Practice areas

Show options
Show options
search

News & Developments

ViewView
Press Releases

CCI FINDS ODISHA TRUCK ASSOCIATIONS GUILTY OF CARTELISATION IN FREIGHT FIXING

The Competition Commission of India (CCI), by its order dated 09 June 2026, found four truck associations i.e. Bhadrasahi/Guali Truck Association (OP-1), Bonai Truck and Tipper Owners’ Association (OP-2), Keonjhar District Truck Owners’ Association (OP-3), and Joda Truck Owners’ Association (OP-4) (collectively, OPs), operating in Odisha engaged in anti-competitive practices in contravention of Section 3 of Competition Act, 2002 (Act). The Indian Steel Association (ISA / Informant), alleged that OPs were engaged in (i) fixing freight rates for transporting mineral-carrying goods carriages, even beyond the maximum freight fixed by the State Transport Authority (STA); (ii) not allowing any independent transporter to transport raw materials from the mines; and (iii) using only smaller trucks (6 and 10-wheeler trucks) for transportation, resulting in higher freights and limiting the quantity that can be dispatched in a truck.   The investigation conducted by the Director General (DG) found that the OPs were indeed issuing their own freight rate charts and resolutions to enforce these higher rates, often through concerted action, which in some instances exceeded the STA-prescribed rates by up to 500%. The DG also concluded that the OPs restricted market access by not allowing independent transporters to operate, as evidenced by resolutions granting exclusivity to association-registered trucks and admissions from office bearers that they deliberately excluded new entrants. However, the allegation that the OPs restricted the use of larger, higher-capacity trucks (like 12-wheelers) in favor of smaller 6 and 10-wheelers was not substantiated by evidence, as no systemic restriction was found.   The CCI, in its analysis, concurred with the DG’s findings on the first two issues, holding that the collective fixing of freight rates by the associations constituted a clear case of price coordination under Section 3(3)(a), and the exclusion of independent transporters amounted to limiting and controlling the market for services under Section 3(3)(b) of the Act.   Accordingly, the CCI held all four OPs in contravention of Section 3(3)(a) and 3(3)(b) read with Section 3(1) of the Act. In terms of liability under Section 48 of the Act, the CCI identified specific office bearers of each association who were responsible for the anti-competitive conduct during their respective tenures. Since the OPs and their individuals have failed to provide their financial details, the CCI held that it would consider appropriate penalty to be imposed on the OPs and their individuals upon receipt of such details.   CCI CLOSES PROCEEDINGS AGAINST SEVERAL CHEMIST AND DRUGGIST ASSOCIATIONS, PHARMACEUTICAL INDUSTRY BODIES AND LEADING DRUG MANUFACTURERS   The CCI, by its order dated 29 June 2026 under Section 26(9) of the Act, closed proceedings against the All India Organisation of Chemists and Druggists (AIOCD), its affiliated chemists' associations, pharmaceutical manufacturers' associations, and several pharmaceutical companies, holding that no contravention of Section 3 of the Act was established.   The case arose from an information filed by the President of the All India Chemists and Distributors Federation (AICDF), alleging that AIOCD and its affiliated associations compelled pharmaceutical companies to obtain No Objection Certificates (NOCs)/Letters of Consent (LOCs) before appointing stockists, mandated Product Information Service (PIS) approvals for launch of new products, fixed trade margins through Memoranda of Understanding (MoUs) executed with manufacturers' associations, restricted appointment of stockists and engaged in boycott practices against non-compliant pharmaceutical companies. The DG concluded that these practices amounted to anti-competitive agreements and found several associations, pharmaceutical companies and individuals liable under Sections 3 and 48 of the Act.   Upon examination of the DG's findings, the CCI observed that the material relied upon by the DG predominantly pertained to the period 2009–2011, whereas the impugned MoU framework had been formally terminated in 2011. The CCI noted that, pursuant to its earlier orders in M/s Santuka Associates Pvt. Ltd. v. All India Organisation of Chemists and Druggists & Ors. (Case No. 20 of 2011), M/s Peeveear Medical Agencies, Kerala v. All India Organisation of Chemists and Druggists & Ors. (Case No. 30 of 2011) and M/s Sandhya Drug Agency v. Assam Drug Dealers Association & Ors. (Case No. 41 of 2011), AIOCD had furnished an Affidavit of Compliance and Undertaking dated 03 January 2014 confirming discontinuation of practices relating to NOCs/LOCs, PIS charges, trade margins and boycott of pharmaceutical products.   The CCI further noted that the DG failed to establish any continuing implementation of these practices after the aforesaid compliance undertaking was furnished or demonstrate that NOC/LOC requirements and PIS approvals remained mandatory in practice. Evidence placed on record also showed that several pharmaceutical companies had independently appointed stockists without obtaining NOCs.   In the absence of cogent evidence establishing any continuing anti-competitive agreement or active participation by the pharmaceutical companies, the CCI declined to sustain the DG's findings. Consequently, no liability was fastened on the identified individuals under Section 48 of the Act.   Accordingly, the CCI held that no contravention of Section 3 of the Act was established against any of the opposite parties and closed the proceedings.   CCI APPROVES FORMATION OF JOINT VENTURE BETWEEN MERCURIA AND TATA INTERNATIONAL   The CCI, by its order, approved the proposed formation of a joint venture between Mercuria Energy Netherlands B.V. (Mercuria) and Tata International Singapore (Pte.) Limited (TISPL).   The proposed combination involves Mercuria acquiring a 51% stake and TISPL acquiring a 49% stake in a newly incorporated joint venture entity i.e. JV Holding Co. (Target), to be established in the Dubai International Financial Centre (DIFC), United Arab Emirates (UAE). As part of the transaction, Tata International Limited's Indian trading business will be transferred to a wholly owned Indian subsidiary (META India), which will subsequently become a wholly owned subsidiary of the joint venture. The joint venture will undertake commodity trading activities including metals, minerals, agricultural products, and oil and gas.   For the purpose of competition assessment, the CCI observed horizontal overlaps between the parties in: (a) market for trading of coal in India (Coal Trading Market) including its narrow segment of trading of thermal coal in India (Thermal Coal Trading Market); and (b) market for trading of crude oil and refined petroleum products in India (Oil Trading Market) including its narrow segment of trading of refined petroleum products in India (Refined Petroleum Trading Market). The CCI also noted that there were no vertical or complementary linkages between the activities of the parties.   The CCI observed that the combined market shares of the parties in the overlapping markets were in the range of [0–5]%. It further noted that these markets are characterised by the presence of several established competitors. Accordingly, the CCI concluded that the proposed combination is unlikely to give rise to foreclosure concerns or cause an appreciable adverse effect on competition (AAEC) in India.   Accordingly, the CCI approved the proposed combination under Section 31(1) of the Act.   CCI APPROVES MERGER OF INDOVIDA INDIA WITH EPL LIMITED   The CCI by its order, approved the proposed merger of Indovida India Private Limited (Indovida India) with EPL Limited (EPL).   The proposed combination forms part of an internal restructuring of the Indorama Ventures Public Company Limited (IVL) group. Pursuant to the transaction, certain IVL group entities engaged in the plastic packaging business will first be consolidated under Indovida India, following which Indovida India will merge with EPL by way of absorption. Upon completion of the merger, EPL will become the resultant entity, with Indorama Netherlands B.V. expected to hold approximately 52% of its shareholding.   For the purpose of competition assessment, the CCI observed a horizontal overlap between the parties in the manufacture and sale of plastic packaging in India. While the IVL group is engaged in the manufacture and sale of rigid plastic packaging, EPL primarily operates in the flexible/collapsible plastic packaging segment. The CCI also noted that there are no existing or potential vertical linkages between the activities of the parties in India.   The CCI observed that the combined market share of the parties in the broader plastic packaging market is in the range of [0–5]% and that the market is characterised by the presence of several credible competitors. Accordingly, the CCI concluded that the proposed combination is unlikely to raise foreclosure concerns or cause an AAEC in India.   Accordingly, the CCI approved the proposed combination under Section 31(1) of the Act. Contributors: Kunal Mehra,  Partner and Head of Antitrust & Competition New Delhi [email protected]   Danish Khan, Associate Partner New Delhi [email protected]  
Phoenix Legal - July 8 2026
Press Releases

Sagus Legal Expands with Second Gurgaon Office at Cyber Hub and Welcomes Aashima Shrivastava as Partner and Head of Gurgaon

National, June 24, 2026: Sagus Legal has announced two strategic milestones in its growth, aimed at strengthening its corporate advisory capabilities. The firm today announced the opening of its new office at Cyber Hub, DLF Cyber City, Gurgaon, and the appointment of Aashima Shrivastava as Partner and Head of Gurgaon in its Corporate, Commercial and Compliance Practice. The new Cyber Hub office positions Sagus Legal at the heart of Gurgaon's most vibrant commercial and professional hub, complementing the firm's existing Gurgaon presence and its New Delhi headquarters. As organisations seek more integrated and commercially aligned legal counsel, Sagus Legal's expanded presence in Gurgaon further strengthens its ability to support clients on complex corporate, commercial, and compliance matters both across India and internationally, and reflects the firm’s commitment to being precisely where its clients are. Together, the new office and Aashima's appointment mark the firm's continued investment in top-tier talent and specialised advisory capability, including emerging technology, AI governance, and digital commercial agreements. Aashima brings over 18 years of experience across corporate governance, labour and employment, cross-border compliance, enterprise risk management, commercial contracting, and strategic advisory. She began her career in 2007, gaining early training and experience at law firms. Transitioning in-house, Aashima held senior legal leadership roles at Boston Consulting Group, where she served as legal lead for India, South-East Asia, Australasia, and the Middle East, working across multiple jurisdictions on high-stakes commercial and regulatory matters. She subsequently led legal affairs for the APAC region at Smiths Group, a global engineering and technology group, where she continued to manage and collaborate with leading international legal practices. Across her career, Aashima has built deep, trusted relationships with premier law firms in the United Kingdom, United States, Singapore, Australia, and across the Middle East and South-East Asia, that will directly benefit Sagus Legal's clients. Commenting on this Shruti Kanodia, Managing Partner, Sagus Legal said “We are delighted to welcome Aashima to the firm. Her career path gives her a perspective that is genuinely rare. Her expertise will benefit Sagus Legal’s existing clients and bring in new clients into the fold with her excellent skills and exposure. Her deep relationships with premier international practices across the UK, US, Singapore, Australia, and the Middle East will be of immediate and direct value to our clients on cross-border work. Combined with her sharp commercial instincts and compliance expertise, she is an outstanding addition to our practice. In her role as Head of Gurgaon, she will also play a pivotal part in establishing our Cyber Hub presence as a destination for the most demanding clients and matters.” Commenting on this Aashima Shrivastava, Partner and Head of Gurgaon, Sagus Legal said “I am thrilled to join Sagus Legal as Partner and Head of Gurgaon. Having worked with and alongside leading international law firms throughout my career, I know the standards that clients in cross-border and complex commercial matters expect, and I am excited to bring that network and experience to bear here. As businesses navigate fast-evolving areas like AI, data protection, and digital regulation alongside traditional commercial and governance needs, there is a real opportunity to deliver integrated, practical counsel that helps clients move with confidence. The new Cyber Hub office is a statement of intent, and I look forward to helping build it.”
Sagus Legal - July 7 2026
Press Releases

Advised and represented Uno Minda Limited in securing approval under Press Note 3 (PN3) from the government of India.

DSK Legal recently advised and represented Uno Minda Limited, one of India’s leading Tier-1 automotive component manufacturers, in securing approval under Press Note 3 (PN3) from the Government of India for its proposed joint venture with a leading Chinese electric vehicle powertrain technology company. The proposed investee, Uno Minda Auto Innovations Pvt. Ltd., a wholly owned subsidiary of Uno Minda incorporated specifically for the joint venture, received investment from Inovance Automotive (HK), a subsidiary of China’s Suzhou Inovance Automotive. The cross-border ownership structure required extensive disclosures relating to beneficial ownership, governance and control across multiple jurisdictions. The DPIIT approval dated 19 June 2026 permits the Chinese entity to invest in an Indian EV components manufacturing venture focused on advanced EV powertrain technologies, including inverters, e-axles, motors, combined charging systems and other high-voltage components for passenger and commercial vehicle OEMs in India. Investments involving Chinese-origin EV technology, automotive manufacturing capabilities and shareholder participation in Indian manufacturing entities fall within one of the most rigorously reviewed categories under India’s foreign investment framework. Given the heightened regulatory sensitivity surrounding Chinese investments under PN3, the transaction underwent extensive scrutiny by multiple governmental and security agencies. The matter involved significant legal, regulatory and structural complexity, including coordination of extensive cross-border documentation, beneficial ownership disclosures, security clearances, sanctions compliance undertakings, valuation certifications and detailed transactional explanations. The DSK Legal team was led by Ajay Shaw (Partner), Samir Malik (Partner) and Gaurav Mistry (Partner), assisted by Akanksha Tiwary (Associate Partner), Riddhi Thakker (Principal Associate) and Manav Asrani (Senior Associate). Mahip Singh (Associate Partner) acted as the engagement and relationship partner for the transaction.
DSK Legal - July 3 2026
Press Releases

DSK Legal advised and assisted Person Centred Software (PCS) on the Indian law aspects of its acquisition of Camascope Limited (Camascope), including the acquisition of its Indian subsidiary, Camascope India Private Limited.

Camascope is one of UK’s most trusted eMAR provider connecting general practitioners, pharmacies, and care providers to improve safety, reduce errors, and enhance operational efficiency across the health and social care industry. PCS’ acquisition of Camascope brings together medication management and digital care solutions ushering in a new stage of care intelligence by connecting Camascope's medication data to the wider care record, moving beyond a record of administration towards smarter insights that guide safer, more connected care. DSK Legal advised PCS on the Indian law aspects of the transaction, including (i) conducting legal due diligence on the Indian subsidiary of Camascope; (ii) reviewing the Share Purchase Agreement; and (iii) assisting with the closing and post-closing actions. Addleshaw Goddard acted as the lead international counsel to PCS, while Eversheds Sutherland represented the shareholders and management of Camascope. The team at DSK Legal advising PCS comprised of Mr. Harvinder Singh (Partner), Mr. Manhar Gulani (Principal Associate), Ms. Devika Rana (Principal Associate), Mr. Brijesh Ranjan Sahoo (Associate), Ms. Sumedha Tewari (Associate) and Ms. Shreya Khandelwal (Associate). Mr. Aparajit Bhattacharya (Partner) acted as the relationship partner and provided strategic inputs on the transaction. Mr. Harvinder Singh (Partner) acted as the lead engagement partner.
DSK Legal - July 3 2026